Circ_0058124 Upregulates MAPK1 Expression to Promote Proliferation, Metastasis and Metabolic Abilities in Thyroid Cancer Through Sponging miR-940

References

• Hugen N, Sloot YJE, Netea-Maier RT, et al. Divergent metastatic patterns between subtypes of thyroid carcinoma results from the nationwide dutch pathology registry. J Clin Endocrinol Metab. 2019. doi:10.1210/clinem/dgz078
   Web of Science ®Google Scholar
• Young S, Harari A, Smooke-Praw S, et al. Effect of reoperation on outcomes in papillary thyroid cancer. Surgery. 2013;154(6):1354–1361; discussion 1361–1352. doi:10.1016/j.surg.2013.06.043
   Web of Science ®Google Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653. doi:10.1038/nrendo.2016.11027418023
   PubMed Web of Science ®Google Scholar
• Ringel MD. Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier. Thyroid. 2011;21(5):487–492. doi:10.1089/thy.2011.212121476892
   PubMed Web of Science ®Google Scholar
• Byeon HK, Kim SB, Oh HS, et al. Clinical analysis of pediatric thyroid cancer: a single medical institution experience of 18 years. Ann Otol Rhinol Laryngol. 2019;128(12):1152–1157.31375033
   PubMed Web of Science ®Google Scholar
• Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428–442. doi:10.1016/j.molcel.2018.06.03430057200
   PubMed Web of Science ®Google Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15(8):995–1005. doi:10.1080/15476286.2018.148665929954251
   PubMed Web of Science ®Google Scholar
• Li T, Sun X, Chen L. Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2019.
   Google Scholar
• Lu J, Zhang PY, Xie JW, et al. Circular RNA hsa_circ_0006848 related to ribosomal protein L6 acts as a novel biomarker for early gastric cancer. Dis Markers. 2019;2019:3863458. doi:10.1155/2019/386345831565098
   PubMed Web of Science ®Google Scholar
• Pan Y, Xu T, Liu Y, et al. Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304. Biochem Biophys Res Commun. 2019;510(2):334–338. doi:10.1016/j.bbrc.2019.01.10830709584
   PubMed Web of Science ®Google Scholar
• Yang Y, Ding L, Li Y, et al. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways. J Cell Physiol. 2019.
   Web of Science ®Google Scholar
• Yao Y, Chen X, Yang H, et al. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res. 2019;38(1):318. doi:10.1186/s13046-019-1321-x31324198
   PubMedGoogle Scholar
• Kwan JY, Psarianos P, Bruce JP, et al. The complexity of microRNAs in human cancer. J Radiat Res. 2016;57(Suppl S1):i106–i111. doi:10.1093/jrr/rrw00926983984
   PubMedGoogle Scholar
• Tutar L, Tutar E, Ozgur A, et al. Therapeutic targeting of microRNAs in cancer: future perspectives. Drug Dev Res. 2015;76(7):382–388. doi:10.1002/ddr.v76.726435382
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature1298624429633
   PubMed Web of Science ®Google Scholar
• Luo H, Xu R, Chen B, et al. MicroRNA-940 inhibits glioma cells proliferation and cell cycle progression by targeting CKS1. Am J Transl Res. 2019;11(8):4851–4865.31497204
   PubMed Web of Science ®Google Scholar
• Liu W, Xu Y, Guan H, et al. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients. Cancer Biomark. 2018;22(3):487–493. doi:10.3233/CBM-17112429843213
   PubMed Web of Science ®Google Scholar
• Hu J, Li C, Liu C, et al. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC. Cancer Biomark. 2017;18(1):87–94. doi:10.3233/CBM-16172328085013
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600–604. doi:10.3109/10799893.2015.103041226096166
   PubMed Web of Science ®Google Scholar
• Wang J, Xiao T, Zhao M. MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP. Onco Targets Ther. 2019;12:7307–7321. doi:10.2147/OTT.S21337131564913
   PubMed Web of Science ®Google Scholar
• Wang J, Yang H, Si Y, et al. Iodine promotes tumorigenesis of thyroid cancer by suppressing Mir-422a and up-regulating MAPK1. Cell Physiol Biochem. 2017;43(4):1325–1336. doi:10.1159/00048184428992617
   PubMedGoogle Scholar
• Mughal BB, Demeneix BA. Endocrine disruptors: flame retardants and increased risk of thyroid cancer. Nat Rev Endocrinol. 2017;13(11):627–628. doi:10.1038/nrendo.2017.12328937689
   PubMedGoogle Scholar
• Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control. 2009;20(1):75–86. doi:10.1007/s10552-008-9219-518766448
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Xu T, Zhang K, Shi J, et al. MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2. Am J Cancer Res. 2019;9(2):250–269.30906627
   PubMed Web of Science ®Google Scholar
• Hou L, Chen M, Yang H, et al. MiR-940 inhibited cell growth and migration in triple-negative breast cancer. Med Sci Monit. 2016;22:3666–3672. doi:10.12659/MSM.89773127731867
   PubMed Web of Science ®Google Scholar
• Li W, Liang J, Zhang Z, et al. MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer. Oncol Rep. 2017;37(5):2743–2750. doi:10.3892/or.2017.555528393232
   PubMed Web of Science ®Google Scholar
• Li XW, Tuergan M, Abulizi G. Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition, invasion and metastasis. Asian Pac J Trop Med. 2015;8(11):937–943. doi:10.1016/j.apjtm.2015.10.00426614994
   PubMed Web of Science ®Google Scholar
• Jiang Z, Shen L, Wang S, et al. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma. Cancer Med. 2019. doi:10.1002/cam4.2584
   Web of Science ®Google Scholar